The News Review:
- PG diploma in clinical trial management
- NEW STRATEGY FR TRANSLATINAL RESEARCH CREATES NEW ARRANGEMENTS FR…
- DAIICHI SANKY LILLY ANNUNCE NEW PRASUGREL HEAD-T-HEAD STUDY.
PG diploma in clinical trial management
Hindu – Nov 5, 2007
Experts have predicted that for the year 2010 the turnover for the industry will be $ 1 billion to five billion. The industry will require anywhere between 20000 and 50000 trained professionals by 2010. Understanding the demand and industry requirements Bilcare Research a service provider to pharmaceutical companies has announced the launch of Bilcare Research Academy in Bangalore where it will offer a Post-Graduate Diploma in Clinical Trial Management in association with the Association of Clinical Research Professionals. This would be the first ACRP-accredited body in the Asian region… The students will also get a free one-year ACRP membership. The academy will be launched formally on December 15. Since clinical research is a fairly new phenomenon in the country Bilcare Research has organised seminars to create awareness about the field in Bangalore from November 16 to 18 and November 23 to 25. For more information on admissions and the seminars visit.
NEW STRATEGY FR TRANSLATINAL RESEARCH CREATES NEW ARRANGEMENTS FR…
Healthcare Republic – Healthcare Republic – Nov 5, 2007
The initiative forms a key part of the developing MRC-NIHR joint strategy for translational research. As part of the strategy a new clinical research programme called the Efficacy and Mechanism Evaluation (EME) Programme will be launched on 1 April 2008. The EME will be funded by the MRC and administered by the NIHR as the lead organisation. The programme aims to support excellent clinical science with an ultimate view to improving health or patient care. Its remit includes clinical trials and evaluative studies which add significantly to our understanding of biological or behavioural mechanisms and processes explore new scientific or clinical principles evaluate clinical efficacy of interventions where proof of concept in humans has already been achieved and the development or testing of new methodologies. The new strategy will see the EME programme working with the already established NIHR Health Technology Assessment (HTA) programme to ensure that promising technologies are carried from the efficacy and safety stage through to being assessed for clinical and cost-effectiveness to the NHS… ""This is an exciting collaboration between the MRC and NIHR in managing clinical research in the UK and in bridging the gaps in translation of research into clinical benefit identified in the Cooksey Review" says Professor Sally Davies Director General of Research and Development at the Department of Health on behalf of the NIHR. "It allows new and existing research programmes to work more closely together to ensure that the excellent biomedical research conducted in the UK is translated into excellent clinical research and real benefits for patients. Recent developments in the infrastructure for clinical research in the UK will facilitate rapid recruitment to trials. " Details of other components of the MRC-NIHR joint strategy for health research covering discovery and exploratory development methodology and human capital will be announced separately. The MRC and NIHR joint arrangement has been developed with the ffice for Strategic Coordination of Health Research. -Ends-Notes to editors: 1. Research proposals for the new funding stream will be sought from January.
DAIICHI SANKY LILLY ANNUNCE NEW PRASUGREL HEAD-T-HEAD STUDY.
Free with registration – AsiaPulse News – AccessMyLibrary.com – Nov 5, 2007
Contact details below. ) MEDIA RELEASE PR28155 Daiichi Sankyo Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel TKY and INDIANAPLIS Nov 4.
